On what evidence-base do we recommend self-monitoring of blood glucose?

Diabetes Research and Clinical Practice
H KolbRüdiger Landgraf

Abstract

Self-monitoring of blood glucose (SMBG) has been considered one major breakthrough in diabetes therapy because, for the first time, patients were able to determine their blood glucose levels during daily life. It seems obvious that this must be of advantage to disease management and clinical outcome, but it has become a nightmare for those trying to provide evidence. Randomised controlled trials have yielded inconsistent results on a benefit of SMBG-based treatment strategies not only in type 2 but - surprisingly - also in type 1 and gestational diabetes. Despite this, SMBG is being considered indispensible in intensive insulin treatment, but is being debated for other clinical settings. When considering the non-RCT based reasons for recommending SMBG in type 1 and gestational diabetes it becomes apparent that the same reasons also apply to type 2 diabetes.

References

Aug 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association·D GordonK R Paterson
Mar 1, 1986·American Journal of Obstetrics and Gynecology·J D GoldbergR L Berkowitz
May 1, 1987·American Journal of Obstetrics and Gynecology·M B LandonE K Main
Apr 1, 1983·Archives of Disease in Childhood·P F MillerJ H Tripp
Dec 1, 1984·American Journal of Obstetrics and Gynecology·U HansonM Stangenberg
Oct 1, 1983·The American Journal of Medicine·M W Varner
Dec 1, 1994·Acta Diabetologica·D B MuchmoreM Miller
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jan 7, 2000·Diabetes Research and Clinical Practice·M G KibriyaA K Khan
Mar 1, 2003·Diabetes Care·Helen JonesUNKNOWN Diabetes Stages of Change (DiSC) Study
Jan 30, 2004·Diabetes Care·Hyuk-Sang KwonKun-Ho Yoon
Nov 25, 2004·Diabetes Care·Dorte M JensenHenning Beck-Nielsen
May 25, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·L A DonnellyUNKNOWN DARTS/MEMO Collaboration
Jun 14, 2005·The New England Journal of Medicine·Caroline A CrowtherUNKNOWN Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group
Oct 18, 2005·The American Journal of Medicine·Richard M BergenstalUNKNOWN Global Consensus Conference on Glucose Monitoring Panel
Dec 24, 2005·The New England Journal of Medicine·David M NathanUNKNOWN Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research
Oct 24, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·J A JohnsonA Edwards
Mar 14, 2007·Diabetes Research and Clinical Practice·A LapollaA Mosca
Jun 1, 2007·Diabetes/metabolism Research and Reviews·Grace McGeochR Andrew Moore

❮ Previous
Next ❯

Citations

Mar 26, 1999·Journal of Urban Health : Bulletin of the New York Academy of Medicine·M San AgustinJ K Allen
Dec 23, 2003·Journal of General Internal Medicine·Joy H LewisLillian Gelberg
Aug 16, 2008·American Journal of Public Health·Joan P YooJane L Holl
Jun 23, 2009·American Journal of Public Health·Tumaini R CokerMark A Schuster
Feb 1, 1997·American Journal of Public Health·B T ZimaB Benjamin
Jun 10, 2014·Indian Journal of Endocrinology and Metabolism·Kranti Shreesh KhadilkarNalini Shah
Feb 22, 2012·Diabetes Research and Clinical Practice·Masayuki Arakawa, Chie Ebato
Feb 24, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·M FranciosiUNKNOWN ROSES Study Group
Oct 16, 2016·Journal of Behavioral Medicine·Barbara StetsonCaroline R Richardson
Jun 7, 2017·Global Health Action·Sujata SapkotaParisa Aslani
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Uriëll L MalandaSandra D M Bot
Aug 28, 2012·Journal of Diabetes Science and Technology·Wendelin Schramm
Sep 6, 2011·Analytica Chimica Acta·Sandeep Kumar VashistFwu-Shan Sheu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.